MORGAN STANLEY - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637139. A total of 13 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$8,080
+12.6%
5,351
+30.3%
0.00%–
Q1 2023$7,176
-14.4%
4,108
-7.4%
0.00%–
Q4 2022$8,388
-6.8%
4,438
-0.9%
0.00%–
Q3 2022$9,000–4,477–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q1 2023.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders